CGS 21680
Alternative Names: CGS 21680CLatest Information Update: 14 May 1997
At a glance
- Originator Novartis
- Class Antiepileptic drugs; Antihypertensives; Antiparkinsonians; Anxiolytics; Neuroprotectants
- Mechanism of Action Adenosine A2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension; Myocardial ischaemia
Most Recent Events
- 14 May 1997 Discontinued-Preclinical for Hypertension in Switzerland (Unknown route)
- 14 May 1997 Discontinued-Preclinical for Myocardial ischaemia in Switzerland (Unknown route)
- 16 Jan 1996 Discontinued-Preclinical for Myocardial ischaemia in USA (Unknown route)